Defining the road map to a UK national lung cancer screening programme

Area of Science:

• Oncology
• Public Health
• Radiology

Background:

• UK National Screening Committee (UKNSC) recommended low-dose CT lung cancer screening in September 2022.
• Evidence from trials demonstrates a reduction in lung cancer mortality, establishing clinical efficacy.
• Further research is required to ensure the deliverability of a national screening program.

Purpose of the Study:

• To describe the consensus among lung cancer screening experts on essential requirements for program implementation.
• To outline key priorities for the effective rollout of a national lung cancer screening initiative.
• To provide a summary of UK expert opinion for international consideration.

Main Methods:

• A multiprofessional group of experts convened for a round-table meeting.
• Participants included clinicians, behavioral scientists, stakeholder organizations, and representatives from NHS England, UKNSC, and the four UK nations.
• The meeting focused on identifying consensus regarding the implementation of lung cancer screening.

Main Results:

• Consensus was reached on critical requirements and priorities for effective lung cancer screening program implementation.
• The review summarizes expert opinions on logistical and practical aspects of screening.
• The National Health Service (NHS) England Targeted Lung Health Check Programme serves as a model for addressing implementation challenges.

Conclusions:

• The UK is a leader in addressing logistical challenges for lung cancer screening through ongoing trials and pilot programs.
• This policy review offers crucial insights for the expansion and evolution of the national screening program.
• The findings provide a valuable resource for countries developing their own lung cancer screening initiatives.